Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Ebos meets guidance as 1H profit more than triples

Ebos meets guidance as 1H profit more than triples, to overhaul executive team

Feb. 19 (BusinessDesk) – Ebos Group said first-half profit more than tripled, meeting its guidance after the acquisition of Symbion, and said its top executives would be replaced by managers of the Australian drug distributor and distributor.

Profit was $49.9 million in the six months ended Dec. 31, up from about $15 million a year earlier, the Christchurch-based company said in a statement. Sales jumped to $3 billion from $755 million. Ebos forecast a profit of $48.7 million on sales of $3.17 billion at its annual meeting in October.

The $1.1 billion cash and scrip Symbion purchase was a game-changer for Ebos, more than tripling annual revenue in a deal that gave Symbion’s owner Zuellig Group a cornerstone 40 percent stake in the New Zealand business and adding to the Hong Kong-based group’s 30 stake in chemist chain PharmacyBrands.

The results announcement marks a changing of the guard at the company that has grown through acquisitions to include medical products distribution, pet products and now pharmaceuticals with 19 acquisitions in 12 years. The shares rose 3.1 percent to $10 and have gained 156 percent in the past five years, almost twice the gains of the NZX 50 Index. It also listed on the ASX in the latest year.

Chairman Rick Christie will retire at the company’s annual meeting in October after 10 years in the role and will be replaced by chief executive Mark Waller.

In turn, Waller will be replaced as CEO by Patrick Davies, who had been CEO of Symbion and chief financial officer Dennis Doherty, who held off retiring pending the Symbion purchase, will be replaced by Symbion CFO John Cullity.

Christie called the changes “the right mix of continuity to maintain our strategic director, proven operational talent and a seamless transition, with an even stronger growth focus.”

Ebos will pay a first-half dividend of 20.5 cents a share on April 4, with a record date of March 14. That’s up from 17.5 cents a year earlier.

The company operates as two main divisions, healthcare and animal care. In the first half, revenue from healthcare soared to $2.8 billion from $673 million a year earlier, reflecting revenue from Symbion, while profit climbed to $52.2 million from $12.8 million.

Animal care, made up of the Procter & Gamble pet care, Eukanuba and IAMS pet food, and the Vitapet grocery brands acquired with the 2011 acquisition of Masterpet Group for $105 million plus debt, lifted sales to $177 million from $81 million and profit gained to $9.5 million from $6.4 million.

Gearing was a relatively mild 26.7 percent and Ebos said it has $390 million in undrawn bank facilities, giving it “significant headroom for future growth.”

The company said it assessed “a number of acquisition opportunities” in the first half though none met its shareholder returns criteria.

With the addition of Symbion, Ebos got A$2.09 billion of its revenue across the Tasman, while New Zealand sales accounted for $649.6 million. Profit from Australia was A$41.7 million and from New Zealand was $14.8 million.

That means the strength of the kiwi dollar against the Australian dollar is a major component of its results. The kiwi was recently at 91.95 Australian cents from 81.44 cents a year ago.

The currency “remains on our radar,” Ebos said in presentation slides today. It gave no specific guidance for the full year while noting that the trading mix has traditionally been skewed 52 percent-48 percent between the first and second halves.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Postnatal Depression: 'The Thief That Steals Motherhood' - Alison McCulloch

Post-natal depression is a sly and cruel illness, described by one expert as ‘the thief that steals motherhood’, it creeps up on its victims, hiding behind the stress and exhaustion of being a new parent, catching many women unaware and unprepared. More>>


DIY: Kiwi Ingenuity And Masking Tape Saves Chick

Kiwi ingenuity and masking tape has saved a Kiwi chick after its egg was badly damaged endangering the chick's life. The egg was delivered to Kiwi Encounter at Rainbow Springs in Rotorua 14 days ago by a DOC worker with a large hole in its shell and against all odds has just successfully hatched. More>>


Trade: Key To Lead Mission To India; ASEAN FTA Review Announced

Prime Minister John Key will lead a trade delegation to India next week, saying the pursuit of a free trade agreement with the protectionist giant is "the primary reason we're going" but playing down the likelihood of early progress. More>>



MYOB: Digital Signatures Go Live

From today, Inland Revenue will begin accepting “digital signatures”, saving businesses and their accountants a huge amount of administration time and further reducing the need for pen and paper in the workplace. More>>

Oil Searches: Norway's Statoil Quits Reinga Basin

Statoil, the Norwegian state-owned oil company, has given up oil and gas exploration in Northland's Reinga Basin, saying the probably of a find was 'too low'. More>>


Modern Living: Auckland Development Blowouts Reminiscent Of Run Up To GFC

The collapse of property developments in Auckland is "almost groundhog day" to the run-up of the global financial crisis in 2007/2008 as banks refuse to fund projects due to blowouts in construction and labour costs, says John Kensington, the author of KPMG's Financial Institutions Performance Survey. More>>


Health: New Zealand's First ‘No Sugary Drinks’ Logo Unveiled

New Zealand’s first “no sugary drinks logo” has been unveiled at an event in Wellington... It will empower communities around New Zealand to lift their health and wellbeing and send a clear message about the damage caused by too much sugar in our diets. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news